Anthony V. Lemmo, CEO of BioDot discusses the demand for COVID-19 tests and the diagnostic manufacturing communities ability to scale-up production. To read the full article go to: https://www.barrons.com/articles/covid-19-test-demand-will-break-global-capacity-without-immediate-investment-51596223970 …
Authors Brianna Abbott, Elbert Wang and Denise Roland discuss COVID-19 antibody testing. After a rocky rollout, higher-quality coronavirus antibody tests have emerged that, among other uses, are beginning to give…
Rachel Robbins Greenough 781-249-9490 rrobbins@greenough.biz BioDot Accelerates Manufacturing to Help Customers Meet Global COVID-19 Testing Demand Automated “lateral flow” dispensing technology is vital step in rapid point-of-care antibody test production…
As the coronavirus pandemic wreaks havoc around the world, one small company in Irvine is doing their part in the highly specialized area of diagnostic test manufacturing equipment. Unlike equipment…
To Our Valued Customers and Partners, We hope you and your family are healthy and safe throughout this health crisis and period of uncertainty. The spread of COVID-19 has brought…
Irvine, CA (March 27, 2020) – BioDot Inc. (BioDot or the Company), a leading manufacturer of automated ultralow volume fluid dispensing systems, announced today that it has been acquired by Artemis…
The COVID-19 virus highlights the urgent need for a rapid, easy to use, Point-of-Care (bedside) test to quickly identify infected patients and help prevent virus transmission. The lateral flow test…
CANCELLED DUE TO COVID-19 From Technologynetworks.com: BioDot announces the Lateral Flow Workshop May 18-20, Amsterdam The Lateral Flow Workshop 2020 is set to be the biggest yet; organized and run…
CANCELLED DUE TO COVID-19 Why you should attend the Lateral Flow Workshop 2020 The BioDot Lateral Flow Workshop is set to return to Amsterdam in 2020 for the biggest ever…
July 18th 2019 BioDot, Inc an automation and liquid handling company with a unique, patent portfolio in low volume dispensing and novel applications in biotechnology, announced today the addition of…
